Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval
Autor: | Cadieux, Benoit, Coleman, Robert, Jafarinasabian, Pegah, Lipton, Allan, Orlowski, Robert Z., Saad, Fred, Scagliotti, Giorgio V., Shimizu, Kazuyuki, Stopeck, Alison |
---|---|
Zdroj: | In Journal of Bone Oncology April 2022 33 |
Databáze: | ScienceDirect |
Externí odkaz: |